Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company is expected to achieve a net profit attributable to shareholders of 1.01-1.02 billion yuan in 2025, representing a year-on-year growth of 10%-11% [4] - In Q4 2025, the company anticipates a net profit of 201-209 million yuan, with a year-on-year increase of 15%-20% [5] - The company is focusing on enhancing its competitive advantages through various strategies, including deepening its 123 strategy, upgrading service quality, increasing investment in technological innovation, and implementing digital transformation [5] - The company has shown significant improvement in cash flow, with a rapid increase in operating cash flow and optimized collection quality [5] - Strategic mergers and international expansion projects are expected to gradually release growth momentum in the long term [5] Financial Performance Summary - The company forecasts revenues of 6.608 billion yuan for 2025, with a growth rate of 9% [6] - The projected net profit for 2026 is 1.171 billion yuan, reflecting a growth rate of 15% [6] - The company maintains a stable gross margin of 49% across the forecast period [7] - The price-to-earnings (P/E) ratio is expected to be 27 for 2025, decreasing to 20 for 2027 [7]

2026 年 01 月 22 日 晨会纪要 研究所： 证券分析师： 余春生 S0350513090001 yucs@ghzq.com.cn 证券研究报告 [Table_Title] 晨会纪要 ——2026 年第 12 期 观点精粹: 最新报告摘要 2025Q4 业绩&2026Q1 指引超预期，资本支出攀升进入加速扩产期--台积电/海外(TSM/2180) 点评报告（港 股美股） 中价格带茶饮强阿尔法，成长空间广阔--古茗/社会服务(01364/2146) 点评报告（港股美股） 2025Q4 业绩预计同环比减亏明显，2026 年新车周期可期--江淮汽车/商用车(600418/212806) 公司点评 1、最新报告摘要 1.1、2025Q4 业绩&2026Q1 指引超预期，资本支出攀升进入加速扩产期-- 台积电/海外(TSM/2180) 点评报告（港股美股） 分析师：陈梦竹 S0350521090003 联系人：邱怡瑄 S0350124070030 事件: 2026 年 1 月 15 日，台积电发布 2025 年 Q4 财报：2025Q4，公司实现收入 10,460.9 亿元新台币/337.3 亿美 元（新台币价 ...

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [2][11]. Core Insights - The company, 古茗 (Gu Ming), is positioned in the tea beverage sector with significant growth potential, driven by rapid product innovation and a strong supply chain [3][7]. - The company has implemented a new franchise policy to encourage existing franchisees to open more stores, which is expected to enhance local brand visibility and operational efficiency [6][8]. - The company has a robust research and development team, with approximately 120 members, focusing on product development and supply chain optimization [7]. Financial Performance and Projections - The company is projected to achieve revenues of RMB 134 billion, RMB 163 billion, and RMB 198 billion for the years 2025, 2026, and 2027 respectively, with a net profit of RMB 27.5 billion, RMB 28.4 billion, and RMB 35.4 billion [9][10]. - The expected growth rates for revenue are 101% in 2025, 76% in 2026, and 71% in 2027, while net profit growth is anticipated at 86% in 2025, 3% in 2026, and 24% in 2027 [10][11]. - The company’s price-to-earnings (P/E) ratio is projected to decrease from 22 in 2025 to 17 in 2027, indicating potential value appreciation [10][11]. Market Position and Strategy - As of November 2025, the company has 13,117 stores, representing a year-on-year increase of 34%, with significant presence in key provinces [9]. - The company’s strategy of regional clustering for store openings is expected to enhance consumer reach and operational management [8][9]. - The company has established a strong supply chain with direct sourcing and self-operated logistics, ensuring product quality and cost control [7].

Investment Rating - The report maintains a "Buy" rating for TSMC (Taiwan Semiconductor Manufacturing Company) [1][10] Core Insights - TSMC's Q4 2025 performance exceeded expectations with revenue of NT$10,460.9 billion (US$337.3 billion), a QoQ increase of 5.7% and YoY growth of 20.5% [3][6] - The company anticipates a nearly 30% revenue growth in 2026, surpassing Bloomberg's consensus estimate of approximately 25% [6][9] - TSMC's capital expenditure guidance for 2026 is set at US$52-56 billion, significantly higher than the consensus estimate of US$46.04 billion [6][9] Financial Performance Summary - In Q4 2025, TSMC achieved a gross margin of 62.3%, which is above the guidance of 59%-61% and Bloomberg's consensus of 60.6% [6][9] - The diluted EPS for Q4 2025 was NT$19.50, exceeding Bloomberg's estimate of NT$18.12 [6][9] - The revenue contribution from advanced processes (7nm and below) accounted for 77% of wafer revenue, with 7nm, 5nm, and 3nm processes contributing 14%, 35%, and 28% respectively [6][9] Future Projections - TSMC projects its revenue for 2026 to be NT$51,287 billion, with net profit expected to reach NT$24,403 billion [9][10] - The company anticipates a mid-to-high 50% CAGR for AI processor revenue over the next five years, while overall revenue CAGR is projected at 25% [7][9] - The target price for TSMC's stock is set at NT$2,286.50, with a corresponding ADR target price of US$434.14, reflecting a 20% premium [9][10]

Group 1: Macroeconomic Insights - In 2025, China's GDP reached 140.2 trillion yuan, with a nominal growth of 5% year-on-year, surpassing global averages and achieving significant milestones during the "14th Five-Year Plan" [4][5][12] - The economic growth rate showed a pattern of high growth in the first half of the year, with quarterly GDP growth rates of 5.4%, 5.2%, 4.8%, and 4.5% respectively [4][5] - The contribution of net exports to economic growth was 32.7%, indicating strong external demand despite trade tensions [5][12] Group 2: Consumption Trends - Retail sales of consumer goods increased by 3.7% year-on-year, with final consumption contributing approximately 52% to economic growth [6][7] - The "trade-in" policy significantly boosted sales in various categories, with retail sales of home appliances and audio-visual equipment rising by 11% and furniture by 14.6% [6][7] - Service consumption grew rapidly, with a 5.5% increase in service retail sales, highlighting a shift towards experiential and health-related spending [7][8] Group 3: Investment Dynamics - Fixed asset investment in 2025 was 48.5 trillion yuan, a decrease of 3.8% year-on-year, with infrastructure investment down by 2.2% and manufacturing investment up by 0.6% [9][10] - High-tech industry investment saw significant growth, with information services up by 28.4% and aerospace manufacturing by 16.9% [11] - The government plans to increase central budget investment in 2026, which is expected to support overall investment recovery [10][11] Group 4: Trade and Export Performance - In 2025, China's total foreign trade reached 45.47 trillion yuan, with exports growing by 6.1% to 26.99 trillion yuan, marking a historical high [12][13] - The structure of exports has shifted towards high-value-added products, with mechanical and electrical products accounting for 61% of total exports [13][14] - Trade dependency on the U.S. has decreased, with exports to the U.S. dropping to 11.1% of total exports in 2025 [14] Group 5: Automotive Industry Developments - The automotive sector saw a weekly increase in stock performance, with the automotive index rising by 0.5% [15][16] - The introduction of the "price commitment" mechanism for electric vehicles is expected to stabilize sales in Europe and promote high-end and localized production [16][18] - Several provinces have opened channels for 2026 vehicle replacement subsidies, indicating government support for the automotive market [17][18] Group 6: AI and Pharmaceutical Innovations - The collaboration between NVIDIA and Eli Lilly aims to leverage AI in drug discovery, with a projected investment of up to $1 billion over five years [24] - AI is expected to transform traditional drug development processes, shifting from labor-intensive methods to data-driven approaches [24] - The pharmaceutical sector has shown resilience, with a 7.08% return in early 2026, despite recent adjustments in stock prices [25]

Group 1 - The overall macro liquidity environment is balanced and slightly loose, with the central bank conducting a net release of 812.8 billion yuan through 7-day reverse repos and a total net injection of 1.7128 trillion yuan during the week [1][8] - The stock market's funding supply is primarily characterized by outflows from broad-based ETFs, while equity fund issuance is on the rise, and the financing balance continues to hit historical highs [2][10] - The net outflow from stock ETFs reached 141.643 billion yuan, with significant inflows into the Sci-Tech 100 and Shanghai Composite Index, while the CSI 300 and Sci-Tech 50 experienced notable outflows [11][17] Group 2 - The stock market's funding demand shows a differentiated pressure structure, with equity financing rebounding to 111.342 billion yuan, while the scale of locked-up shares being released decreased to 52.42 billion yuan [3][19] - The number of newly established active equity funds increased, with a total issuance of 4.597 billion units, reflecting a recovery compared to the previous week [10][12] - The net reduction in industrial capital increased to 20.449 billion yuan, with significant reductions observed in the electronics, communication, and basic chemical industries [21][28]

Investment Rating - The report maintains a "Neutral" rating for the pharmaceutical and biotechnology industry [7][49]. Core Insights - The pharmaceutical sector has experienced a decline of 0.68% recently, ranking 19th among 31 primary sub-industries. The chemical pharmaceuticals, biological products, medical devices, pharmaceutical commerce, traditional Chinese medicine, and medical services have shown varying performance, with the medical services sector increasing by 3.29% [12][26]. - The collaboration between NVIDIA and Eli Lilly to establish an AI joint innovation lab aims to address long-standing challenges in the pharmaceutical industry, with a projected investment of up to $1 billion over five years [13]. - Tempus AI reported a revenue of approximately $1.27 billion for 2025, marking an 83% year-on-year increase, driven by significant growth in diagnostic services [14]. Summary by Sections Recent Performance - The pharmaceutical sector's return since the beginning of 2026 is 7.08%, outperforming the CSI 300 index, which returned 2.20%. However, the pharmaceutical sector lagged behind the CSI 300 by 4.88 percentage points [26]. Market Dynamics - The pharmaceutical sector's valuation is currently at 34.5 times PE based on 2026 earnings forecasts, representing a 35% premium over the overall A-share market (excluding financials). The TTM valuation stands at 30.4 times PE, below the historical average of 35.0 times PE [29]. Individual Stock Performance - Notable stock performances include Baolait and Hualan Biological, which saw increases of 48.76% and 32.72%, respectively, while stocks like Xiangrikui and Luyuan Pharmaceutical experienced declines of 37.48% and 26.62% [35]. Key Companies to Watch - The report highlights companies such as Sanofi, Innovent Biologics, and others as key focuses for potential investment opportunities [40].

Investment Rating - The report maintains a "Recommended" rating for the automotive industry [1] Core Insights - The implementation of the China-Europe electric vehicle price commitment mechanism is expected to stabilize sales expectations for Chinese electric vehicles in Europe and promote the high-end and localized transformation of automakers [5][13] - Multiple provinces have opened applications for the 2026 automotive replacement subsidy, indicating a clear path for local governments to implement the policy [14] - Great Wall Motors has launched the "Guiyuan" platform, which is the world's first native AI all-power platform, designed to support various power forms and enhance development efficiency [6][14] - The report expresses a positive outlook for 2026, highlighting opportunities in the high-end upgrade of domestic brands and the acceleration of smart technology penetration [15][16] Summary by Sections Recent Performance - The automotive sector outperformed the Shanghai Composite Index with a 1-week increase of 0.5% from January 12 to January 16, 2026, while the Shanghai Composite Index decreased by 0.4% [17] - The performance of individual stocks varied, with notable increases in companies like Ideal Auto (+2.4%) and declines in others like Li Auto (-3.5%) [17][23] Key Companies and Earnings Forecast - Key companies recommended include: - Jianghuai Automobile - Leap Motor - Great Wall Motors - BYD - SAIC Motor - China National Heavy Duty Truck [7][8] - Earnings per share (EPS) forecasts for selected companies show growth, with Great Wall Motors expected to reach an EPS of 2.03 in 2026 [8] Industry Indicators - In December 2025, automotive production and sales reached 3.296 million and 3.272 million units, respectively, with a year-on-year decrease of 2.1% and 6.2% [42] - New energy vehicles accounted for approximately 52% of total new vehicle sales, indicating a significant market shift towards electrification [42]

Economic Overview - In 2025, China's nominal GDP reached 140.2 trillion yuan, marking a significant increase with a cumulative growth of approximately 36.7 trillion yuan during the "14th Five-Year Plan" period[6] - The actual GDP growth rate for 2025 was 5%, surpassing global average growth of 2.7% and growth rates of developed economies at 1.7%[6] Economic Growth Dynamics - Quarterly GDP growth rates were 5.4%, 5.2%, 4.8%, and 4.5%, indicating a trend of high growth followed by stability throughout the year[6] - The contribution of net exports to economic growth was 32.7%, demonstrating resilience against trade conflicts[7] Structural Changes - The industrial sector showed robust performance with industrial added value growing by 5.9% and the service sector index increasing by 5.4%[7] - High-end manufacturing saw significant growth, with drone and industrial robot production increasing by 37.3% and 28%, respectively[8] Consumer Trends - Retail sales of consumer goods grew by 3.7%, with final consumption contributing approximately 52% to economic growth[8] - The service sector's retail sales increased by 5.5%, outpacing goods retail growth by 1.7 percentage points[8] Investment Insights - Fixed asset investment (excluding rural households) totaled 48.5 trillion yuan, a decrease of 3.8%, with real estate investment dropping by 17.2%[10] - High-tech industry investment grew significantly, with information services up by 28.4% and aerospace manufacturing by 16.9%[13] Trade Performance - Total foreign trade reached 45.47 trillion yuan, a 3.8% increase, with exports at 26.99 trillion yuan, growing by 6.1%[14] - The share of high-tech products in exports rose to 61%, with high-tech exports increasing by 13.2%[15]

Group 1: BYD / Passenger Vehicles - BYD reported a total sales volume of 4.6024 million vehicles in 2025, representing a year-on-year increase of 7.73% despite a monthly sales decline of 18.3% in December 2025 [3][4] - The sales of the high-end model "Fangchengbao" surged by 345.5% year-on-year in December 2025, with annual sales reaching 235,000 units, indicating a strong performance in the high-end market segment [4] - BYD's overseas sales reached 1.0496 million units in 2025, a year-on-year increase of 145%, solidifying its position as the global leader in the new energy vehicle market [4][5] Group 2: Kangnuo Ya-B / Biopharmaceuticals - Kangnuo Ya's innovative biological agent, Kangyueda, has been included in the national medical insurance reimbursement list, enhancing patient accessibility and reducing financial burdens [6][7] - The drug shows significant efficacy in treating moderate to severe atopic dermatitis, with response rates of 92.5% and 77.1% for EASI-75 and EASI-90, respectively [7] - Revenue projections for Kangnuo Ya are estimated at 741 million yuan for 2025, increasing to 1.9 billion yuan by 2027, with a "buy" rating assigned based on the growth potential of its innovative product pipeline [8] Group 3: Lithium Carbonate and Glyphosate Industry - The lithium carbonate price increased by 14.69% week-on-week, reaching 140,500 yuan per ton, driven by strong demand in the energy storage sector [17] - Glyphosate prices rose by 4.78% week-on-week, reflecting a recovery in demand and a tightening supply situation in the market [17][12] - The chemical industry is expected to experience a revaluation due to supply-side changes and a potential shift towards higher dividend yields as capacity expansion slows [12][13] Group 4: Shenli Environment / General Equipment - Shenli Environment is focusing on expanding production capacity and overseas markets, with a significant increase in orders for high-efficiency liquid cooling equipment [36][38] - The company aims to enhance its product delivery capabilities through the establishment of new intelligent production lines, ensuring timely and high-quality order fulfillment [38] - The data service segment is projected to become a core growth driver, with substantial order growth expected in the coming years [40][41] Group 5: Textile and Apparel Industry - The textile manufacturing sector is expected to improve as tariff impacts wane, with a focus on leading manufacturers benefiting from stable operations and improved order flows [43][44] - The domestic sports footwear and apparel market is showing signs of recovery, particularly among high-end brands, with expectations for accelerated growth in 2026 [44] - The luxury goods market in China is gradually recovering, driven by wealth effects and improved retail performance, with a projected growth of approximately 4% in 2026 [45]